An Evaluation of Nonacademic Predictors of Success in a Doctor of Pharmacy Program von Mahan, Rebecca J., Mathys, Monica, Minze, Molly G., Sherrod, Sonya E., Seifert, Charles F.

Volltext

An Evaluation of Nonacademic Predictors of Success in a Doctor of Pharmacy Program von Seifert, Charles F, Mahan, Rebecca J, Mathys, Monica, Minze, Molly G, Sherrod, Sonya E

Volltext

Envisioning the Future of Student Success: Report of the 2022–2023 AACP Student Affairs Standing Committee von Robinson, Evan T., Cochrane, Zara Risoldi, Akiyode, Oluwaranti, Chahine, Elias B., Culhane, James M., Do, Duc P., Franson, Kari L., Minze, Molly G., Ross, Libby J.

Volltext

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated von Irons, Brian K, Minze, Molly G

Volltext

Achieving cholesterol goals with low-cost 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors von Klein, Mary S, Koffarnus, Robin L, Minze, Molly G, Ochoa, Pamella

Volltext

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults von Minze, Molly G., Klein, Mary S., Terrell, Brian T.

Volltext

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes von Edwards, Krystal L, Minze, Molly G

Volltext

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide von Minze, Molly G, Chastain, Lisa M

Volltext

Once-Weekly Exenatide: An Extended-Duration Glucagon-Like Peptide Agonist for the Treatment of Type 2 Diabetes Mellitus von Minze, Molly G., Klein, Mary S., Jernigan, Michelle J., Wise, Stephen L., Frugé, Kristian

Volltext

Removing barriers to insulin use von Minze, Molly G, Dalal, Kavita, Irons, Brian K

Volltext

Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue? von Minze, Molly G., Kwee, Yu-Yu, Hall, Ronald G.

Volltext

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes von Edwards, Krystal, Minze, Molly

Volltext

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum] von Irons, Brian, Minze, Molly

Volltext

Guidelines for therapeutic interchange—2022 von Welty, Timothy E., Hilaire, Michelle L., Frantzen, Leah M., Achey, Thomas S., Minze, Molly G., Japs, Kelsey L., Elliott, Amber N., Brasher, Cynthia A., May, Dianne W., Mosley, Scott A., Johnson, Corinne G., Grimm, Derek L., Huffman, Sara

Volltext

Removing barriers to insulin use: patients with type 2 diabetes and their physicians are often reluctant to begin insulin therapy - despite evidence of its efficacy. Here's help in... von Minze, Molly G, Dalal, Kavita, Irons, Brian K

Volltext

PRN OPINION PAPER: Application of precision medicine across pharmacy specialty areas von Caudle, Kelly E., Gammal, Roseann S., Karnes, Jason H., Afanasjeva, Janna, Anderson, Keri C., Barreto, Erin F., Beavers, Craig, Bhat, Shubha, Birrer, Kara L., Chahine, Elias B., Ensor, Christopher R., Flowers, Stephanie A., Formea, Christine M., George, Jomy M., Gosser, Rena A., Hebert, Mary F., Karaoui, Lamis R., Kolpek, Jimmi Hatton, Lee, James C., Leung, Jonathan G., Maldonado, Angela Q., Minze, Molly G., Pulk, Rebecca A., Shelton, Chasity M., Sheridan, Maria, Smith, Michael A., Soefje, Scott, Tellez‐Corrales, Eglis, Walko, Christine M., Cavallari, Larisa H.

Volltext

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults von Molly G. Minze, Mary S. Klein, Brian T. Terrell

Volltext